Testing effectiveness (Phase 2)Study completedNCT00044057
What this trial is testing
Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
Who this might be right for
Acute Ischemic Stroke
Astellas Pharma Inc